▎Armstrong2025年5月30日-6月3日,美国临床肿瘤学会(ASCO)年会将在伊利诺伊州芝加哥市举行。4月23日,ASCO官网已经公布所有中选的摘要标题,乐普生物EGFR ADC新药Becotatug Vedotin(MRG003)治疗晚期鼻咽癌注册性随机对照IIb期临床数据入选late-breaking abstracts(重要突破摘要)。此外,乐普生物PD-1抗体普特利单抗治疗MSI...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.